PAR 2.38% 20.5¢ paradigm biopharmaceuticals limited..

experience, page-13

  1. 294 Posts.
    lightbulb Created with Sketch. 114

    @MixedBag.....I'm not especially concerned as to your views on the chances of a successful Phase 3, but I'm more interested in this...

    ".....we are definitely not being given all the info by PAR management and the researchers..."

    What basis do you have for saying this?
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.